HK1047434B - 噻吩並嘧啶化合物 - Google Patents

噻吩並嘧啶化合物

Info

Publication number
HK1047434B
HK1047434B HK02109063.1A HK02109063A HK1047434B HK 1047434 B HK1047434 B HK 1047434B HK 02109063 A HK02109063 A HK 02109063A HK 1047434 B HK1047434 B HK 1047434B
Authority
HK
Hong Kong
Prior art keywords
thienopyrimidines
phosphodiesterase inhibitors
phosphodiesterase
inhibitors
Prior art date
Application number
HK02109063.1A
Other languages
English (en)
Other versions
HK1047434A1 (en
Inventor
Jonas Rochus
Schelling Pierre
Kluxen Franz-Werner
Christadler Maria
Original Assignee
默克專利股份公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 默克專利股份公司 filed Critical 默克專利股份公司
Publication of HK1047434A1 publication Critical patent/HK1047434A1/xx
Publication of HK1047434B publication Critical patent/HK1047434B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK02109063.1A 1999-06-19 2002-12-13 噻吩並嘧啶化合物 HK1047434B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19928146A DE19928146A1 (de) 1999-06-19 1999-06-19 Thienopyrimidine
PCT/EP2000/005278 WO2000078767A1 (de) 1999-06-19 2000-06-07 Thienopyrimidine als phosphodiesterase hemmer

Publications (2)

Publication Number Publication Date
HK1047434A1 HK1047434A1 (en) 2003-02-21
HK1047434B true HK1047434B (zh) 2005-01-28

Family

ID=7911858

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02109063.1A HK1047434B (zh) 1999-06-19 2002-12-13 噻吩並嘧啶化合物

Country Status (24)

Country Link
US (1) US6787548B1 (zh)
EP (1) EP1189907B1 (zh)
JP (1) JP2003502429A (zh)
KR (1) KR20020010719A (zh)
CN (1) CN1144806C (zh)
AR (1) AR024380A1 (zh)
AT (1) ATE285412T1 (zh)
AU (1) AU767273B2 (zh)
BR (1) BR0011778A (zh)
CA (1) CA2375278A1 (zh)
CZ (1) CZ293901B6 (zh)
DE (2) DE19928146A1 (zh)
ES (1) ES2234613T3 (zh)
HK (1) HK1047434B (zh)
HU (1) HUP0201730A3 (zh)
MX (1) MXPA01013228A (zh)
NO (1) NO20016201L (zh)
PL (1) PL351822A1 (zh)
PT (1) PT1189907E (zh)
RU (1) RU2238274C2 (zh)
SK (1) SK18222001A3 (zh)
UA (1) UA72256C2 (zh)
WO (1) WO2000078767A1 (zh)
ZA (1) ZA200200440B (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19944604A1 (de) * 1999-09-17 2001-03-22 Merck Patent Gmbh Aminderivate
DE10001021A1 (de) * 2000-01-13 2001-07-19 Merck Patent Gmbh Pharmazeutische Zubereitung
DE10010612A1 (de) * 2000-03-03 2001-09-27 Merck Patent Gmbh Verwendung von PDE V-Inhibitoren
DE10017947A1 (de) * 2000-04-11 2001-10-25 Merck Patent Gmbh Verfahren zur Herstellung benzo-annelierter Heterocyclen
DE10031585A1 (de) * 2000-06-29 2002-01-10 Merck Patent Gmbh 2-Aminoalkyl-thieno[2,3-d]pyrimidine
DE10107261B4 (de) * 2001-02-16 2005-03-10 Merck Patent Gmbh Pharmazeutische Zusammensetzung
WO2003035653A1 (fr) * 2001-10-26 2003-05-01 Nippon Soda Co.,Ltd. Compose pyridothienopyrimidine et son sel
US7678363B2 (en) 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2804603A1 (en) 2012-01-10 2014-11-26 President and Fellows of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19644228A1 (de) * 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine
DE19819023A1 (de) 1998-04-29 1999-11-04 Merck Patent Gmbh Thienopyrimidine

Also Published As

Publication number Publication date
RU2238274C2 (ru) 2004-10-20
UA72256C2 (uk) 2005-02-15
WO2000078767A1 (de) 2000-12-28
CN1355805A (zh) 2002-06-26
US6787548B1 (en) 2004-09-07
EP1189907A1 (de) 2002-03-27
EP1189907B1 (de) 2004-12-22
CZ20014422A3 (cs) 2002-03-13
CN1144806C (zh) 2004-04-07
DE19928146A1 (de) 2000-12-21
PT1189907E (pt) 2005-05-31
DE50009042D1 (en) 2005-01-27
ZA200200440B (en) 2003-06-25
CA2375278A1 (en) 2000-12-28
ATE285412T1 (de) 2005-01-15
AR024380A1 (es) 2002-10-02
PL351822A1 (en) 2003-06-16
BR0011778A (pt) 2002-04-23
ES2234613T3 (es) 2005-07-01
NO20016201D0 (no) 2001-12-18
AU767273B2 (en) 2003-11-06
JP2003502429A (ja) 2003-01-21
MXPA01013228A (es) 2002-07-02
HK1047434A1 (en) 2003-02-21
AU5220400A (en) 2001-01-09
SK18222001A3 (sk) 2002-06-04
NO20016201L (no) 2001-12-18
KR20020010719A (ko) 2002-02-04
HUP0201730A2 (en) 2002-09-28
HUP0201730A3 (en) 2004-12-28
CZ293901B6 (cs) 2004-08-18

Similar Documents

Publication Publication Date Title
IL148614A0 (en) Pteridinones as kinase inhibitors
IL181957A0 (en) Pyrimidine-4-one derivatives as ldl-pla2 inhibitors
IL154839A0 (en) Xanthine phosphodiesterase v inhibitors
GB9900416D0 (en) Inhibitors
AU6117801A (en) Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
HK1066546A1 (en) Trifluoromethylpurines as phosphodiesterase 4 inhibitors
PL369728A1 (en) Pyrrolopyrimidines as phosphodiesterase vii inhibitors
PL373301A1 (en) Phosphodiesterase 4 inhibitors
PL355099A1 (en) Pyrrole derivatives as phosphodiesterase vii inhibitors
PL351822A1 (en) Thienopyrimidines as phosphodiesterase inhibitors
PL355022A1 (en) Imidazopyridine derivatives as phosphodiesterase vii inhibitors
AU2954102A (en) (dihydro)isoquinoline derivatives as phosphodiesterase inhibitors
IL150114A0 (en) Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
IL156479A0 (en) Substituted-8-arylquinoline phosphodiesterase-4 inhibitors
PL354979A1 (en) Tetrahydrothiopy ranphthalazinone derivatives as pde4 inhibitors
EP1153022A4 (en) PROTEASE INHIBITORS
PL355020A1 (en) Imidazole derivatives as phosphodiesterase vii inhibitors
AU2002224835A1 (en) Dihydroisoquinolines as novel phosphodiesterase inhibitors
GB9922125D0 (en) Phosphodiesterase enzymes
HUP0202614A3 (en) Use of thienopyrimidines
GB0014861D0 (en) Novel telomerase inhibitors
SI1296981T1 (en) Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
SI1226143T1 (en) Imidazopyridine derivatives used as phosphodiesterase vii inhibitors
GB9900413D0 (en) Inhibitors
GB9929341D0 (en) Inhibitors

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20080607